XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
EQUITY METHOD INVESTMENTS (Details Narrative)
3 Months Ended 6 Months Ended
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
CAD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2024
EUR (€)
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Gain on extinguishment of debt $ 0 $ 2,257   $ 0   $ 1,910,770  
Cosmo Farmacy LP [Member]              
Initial share capital | €         € 150,000    
Initial share capital increased | €         500,000    
Pharmacy license value | €         € 350,000    
Maturity period of license     30 years 30 years 30 years    
Ownership equity 70.00%     70.00%      
Cash contributed to limited partner | €         € 30    
Equity ownership remaining 30.00%     30.00%      
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member]              
Upfront cash received     $ 2,000,000        
Fair value of settlement account       $ 1,554,590      
Gain on extinguishment of debt       $ 1,554,590      
Agreement term     five (5) years five (5) years five (5) years    
Cash received upon gross sales     $ 2,750,000        
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales One [Member]              
Cash received upon gross sales     2,750,000        
Gross sales     13,000,000        
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]              
Cash received upon gross sales     2,750,000        
Gross sales     $ 6,500,000        
Share Exchange Agreement [Member] | ICC [Member]              
Investement $ 160,665     $ 160,665     $ 165,930